Search Results - "Gaze, D C"

Refine Results
  1. 1

    Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin by Roy, D, Quiles, J, Gaze, D C, Collinson, P, Kaski, J C, Baxter, G F

    Published in Heart (British Cardiac Society) (01-01-2006)
    “…The dismutation of *O2- by extracellular superoxide dismutase (SOD) present in serum undoubtedly occurs in vitro, just as it does in vivo. [...]the presence of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T by Sharma, R, Gaze, D C, Pellerin, D, Mehta, R L, Gregson, H, Streather, C P, Collinson, P O, Brecker, S J D

    Published in Heart (British Cardiac Society) (01-06-2006)
    “…Objectives: To identify in a prospective observational study the cardiac structural and functional abnormalities and mortality in patients with end stage renal…”
    Get full text
    Journal Article
  4. 4

    Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction by Sinha, M K, Vazquez, J M, Calvino, R, Gaze, D C, Collinson, P O, Kaski, J C

    Published in Heart (British Cardiac Society) (01-12-2006)
    “…METHODS We simultaneously measured coronary sinus and arterial lactate concentrations and plasma IMA levels before and after balloon inflation in 10 patients…”
    Get full text
    Journal Article
  5. 5

    Role of “Ischemia Modified Albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes by Sinha, M K, Roy, D, Gaze, D C, Collinson, P O, Kaski, J-C

    Published in Emergency medicine journal : EMJ (01-01-2004)
    “…Background: Diagnosis of cardiac ischaemia in patients attending emergency departments (ED) with symptoms of acute coronary syndromes is often difficult…”
    Get full text
    Journal Article
  6. 6

    Prolonged exercise should be considered alongside typical symptoms of acute myocardial infarction when evaluating increases in cardiac troponin T by Shave, R E, Whyte, G P, George, K, Gaze, D C, Collinson, P O

    Published in Heart (British Cardiac Society) (01-09-2005)
    “…[...]caution is advised on the use of cTnT cut off criteria in the diagnosis of AMI in patients who have recently completed a bout of prolonged exercise. Work…”
    Get full text
    Journal Article
  7. 7

    Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys™ 1010 and 2010 analysers by Collinson, P.O., Barnes, S.C., Gaze, D.C., Galasko, G., Lahiri, A., Senior, R.

    Published in European journal of heart failure (15-03-2004)
    “…The Elecsys NT‐proBNP assay is based on two polyclonal antibodies directed at residues 1–21 and 39–50 of the NT‐proBNP molecule. Analytical performance was…”
    Get full text
    Journal Article
  8. 8

    Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race by Shave, R E, Dawson, E, Whyte, G, George, K, Ball, D, Gaze, D C, Collinson, P O

    Published in International journal of sports medicine (01-10-2002)
    “…Cardiac damage has recently been implicated in the aetiology of "exercise induced cardiac dysfunction". The humoral markers of cardiac damage that have been…”
    Get more information
    Journal Article
  9. 9

    Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE) by Collinson, P O, Gaze, D C, Thokala, P, Goodacre, S

    “…To test the diagnostic accuracy for detecting an acute myocardial infarction (AMI) using highly sensitive troponin assays and a range of new cardiac biomarkers…”
    Get full text
    Journal Article
  10. 10

    Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease by Sharma, R, Gaze, D C, Pellerin, D, Mehta, R L, Gregson, H, Streather, C P, Collinson, P O, Brecker, S J D

    Published in Heart (British Cardiac Society) (01-10-2006)
    “…Ea ratio 6.18 (2.17 to 9.94) 0.006 Significant CAD 5.87 (2.96 to 9.14) 0.02 CAD, coronary artery disease; DSE, dobutamine stress echocardiography; HR, hazard…”
    Get full text
    Journal Article
  11. 11

    Utility of admission cardiac troponin and “Ischemia Modified Albumin” measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department by Collinson, P O, Gaze, D C, Bainbridge, K, Morris, F, Morris, B, Price, A, Goodacre, S

    Published in Emergency medicine journal : EMJ (01-04-2006)
    “…Objective: To assess if the combination of cardiac troponin (cTn) and Ischemia Modified Albumin (IMA) can be used for early exclusion of acute myocardial…”
    Get full text
    Journal Article
  12. 12

    Changes in blood gas samples produced by a pneumatic tube system by Collinson, P O, John, C M, Gaze, D C, Ferrigan, L F, Cramp, D G

    Published in Journal of clinical pathology (01-02-2002)
    “…Aims: To investigate the effect of a pneumatic tube system (PTS) on the results of samples sent for blood gas analysis to a central laboratory. Methods: Blood…”
    Get full text
    Journal Article
  13. 13

    Maternal cardiac function in early pregnancies with high uterine artery resistance by Prefumo, F., Sharma, R., Brecker, S. J. D., Gaze, D. C., Collinson, P. O., Thilaganathan, B.

    Published in Ultrasound in obstetrics & gynecology (01-01-2007)
    “…Objective To compare the maternal cardiac function and serum concentration of cardiac troponin T (cTnT) and N‐terminal pro‐B‐type natriuretic peptide…”
    Get full text
    Journal Article
  14. 14

    The perils, pitfalls and opportunities of using high sensitivity cardiac troponin by Gaze, D C

    Published in Current medicinal chemistry (01-08-2011)
    “…Cardiac troponins (cTn) are considered to be the 'gold standard' biomarker for the diagnosis of acute coronary syndrome (ACS); a pathological spectrum which…”
    Get more information
    Journal Article
  15. 15

    First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development by Prefumo, Federico, Gaze, David C, Papageorghiou, Aris T, Collinson, Paul O, Thilaganathan, Baskaran

    Published in Human reproduction (Oxford) (01-07-2007)
    “…BACKGROUND A hypoxic intrauterine environment is believed to play a pivotal role in physiological trophoblast development. Ischaemia-modified albumin (IMA) is…”
    Get full text
    Journal Article
  16. 16

    Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention by SINHA, Manas K, GAZE, David C, TIPPINS, John R, COLLINSON, Paul O, KASKI, Juan Carlos

    Published in Circulation (New York, N.Y.) (20-05-2003)
    “…Ischemia modified albumin (IMA; Ischemia Technologies, Inc) blood levels rise in patients who develop ischemia during percutaneous coronary intervention (PCI)…”
    Get full text
    Journal Article
  17. 17

    Cardiac troponin T in female athletes during a two-day mountain marathon by Shave, R E, Dawson, E, Whyte, P G, George, K, Ball, D, Gaze, C D, Collinson, P

    Published in Scottish medical journal (01-05-2003)
    “…Equivocal studies exist on the potential of cardiac damage following prolonged endurance exercise. The aim of the study was to examine humoral markers of…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite by Collinson, P.O., Gaze, D.C., Stubbs, P.J., Swinburn, J., Khan, M., Senior, R., Lahiri, A.

    Published in Clinical biochemistry (01-07-2006)
    “…To evaluate the diagnostic and prognostic role of the Immulite cTnI assay for the detection of acute coronary syndromes (ACS). 150 males and 63 females with a…”
    Get full text
    Journal Article
  20. 20

    The role of existing and novel cardiac biomarkers for cardioprotection by Gaze, David C

    “…Cardioprotection is an all-encompassing term for physico-biochemical or therapeutic interventions which slow or ameliorate the progression of cardiomyocyte…”
    Get more information
    Journal Article